Nuveen Asset Management, LLC Gilead Sciences, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 5,208,321 shares of GILD stock, worth $616 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

5,208,321

Previous 4,483,828 16.16%

Holding current value

$616 Million

Previous $376 Million 28.01%

% of portfolio

0.14%

Previous 0.11%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$83.95 - $97.9 $60.8 Million - $70.9 Million	724,493 Added 16.16%	5,208,321 $481 Million
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $33.5 Million - $42.2 Million	-502,589 Reduced 10.08%	4,483,828 $376 Million
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $226 Million - $261 Million	-3,584,153 Reduced 41.82%	4,986,417 $342 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $212 Million - $259 Million	-2,964,905 Reduced 25.7%	8,570,570 $628 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $8.89 Million - $10.1 Million	121,326 Added 1.06%	11,535,475 $934 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $119 Million - $130 Million	1,614,798 Added 16.48%	11,414,149 $855 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $40.3 Million - $46 Million	530,242 Added 5.72%	9,799,351 $755 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $47.5 Million - $54.1 Million	614,202 Added 7.1%	9,269,109 $769 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $41.3 Million - $59.4 Million	663,387 Added 8.3%	8,654,907 $743 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $66.9 Million - $76.4 Million	1,123,549 Added 16.36%	7,991,520 $493 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $44.3 Million - $49.8 Million	-766,659 Reduced 10.04%	6,867,971 $425 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $78.9 Million - $98.8 Million	-1,361,924 Reduced 15.14%	7,634,630 $455 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $18.1 Million - $20.5 Million	-278,343 Reduced 3.0%	8,996,554 $653 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $27.6 Million - $29.7 Million	407,151 Added 4.59%	9,274,897 $648 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $9.45 Million - $10.3 Million	148,891 Added 1.71%	8,867,746 $611 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $235 Million - $268 Million	3,918,666 Added 81.64%	8,718,855 $564 Million
Q4 2020 May 17, 2021	BUY	$56.65 - $64.55 $12.1 Million - $13.8 Million	213,662 Added 4.66%	4,800,189 $280 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $8.97 Million - $10.2 Million	-158,356 Reduced 3.34%	4,586,527 $267 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $101 Million - $127 Million	-1,626,848 Reduced 25.53%	4,744,883 $300 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $439 Million - $510 Million	-6,067,783 Reduced 48.78%	6,371,731 $490 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $259 Million - $332 Million	4,135,434 Added 49.8%	12,439,514 $930 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $93.2 Million - $103 Million	-1,512,563 Reduced 15.41%	8,304,080 $540 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $1.92 Million - $2.12 Million	-30,716 Reduced 0.31%	9,816,643 $622 Million
Q2 2019 Aug 15, 2019	BUY	$61.87 - $69.38 $563 Million - $631 Million	9,094,586 Added 1208.14%	9,847,359 $665 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $11.8 Million - $13.2 Million	188,180 Added 33.33%	752,773 $48.9 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $3.96 Million - $5.17 Million	-65,430 Reduced 10.39%	564,593 $35.3 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $296,025 - $327,754	4,153 Added 0.66%	630,023 $48.6 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $3.87 Million - $4.52 Million	-59,721 Reduced 8.71%	625,870 $44.3 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $21.2 Million - $25.8 Million	-290,812 Reduced 29.78%	685,591 $51.7 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $8.25 Million - $9.69 Million	116,003 Added 13.48%	976,403 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $62 Million - $73.5 Million	860,400	860,400 $69.7 Million

Others Institutions Holding GILD

# of Institutions

2,330

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $148B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Gilead Sciences, Inc. Transaction History